Fagron N.V.

AGM Information • May 14, 2013

Annual General Meeting of Arseus approves all motions

Waregem (Belgium) / Rotterdam (The Netherlands)¹ , 14 May 2013 – The Annual General Meeting of Shareholders, held on 13 May 2013, has approved all motions put forward by the Board of Directors of Arseus.

The shareholders adopted, amongst other things, the annual accounts 2012 and determined the dividend over 2012 at € 0.60 per share. The shareholders granted full discharge to the directors and the statutory auditor who were active during the financial year 2012.

The gross dividend paid out by Arseus (coupon number 6) will amount to € 0.60 per share. The net dividend will amount to € 0.45 per share, being gross dividend less 25% Belgian dividend withholding tax.

The timetable is as follows: 15 May Ex-dividend quotation 17 May Record date 20 May Dividend payable

In the event of any discrepancy between the English translation and the original Dutch version of this press release, the latter shall prevail.

For more information:

Constantijn van Rietschoten Director of Corporate Communications +31 88 33 11 222 (office) +31 6 536 91 585 (mobile) constantijn.van.rietschoten@arseus.com

¹ This press release was sent out by Arseus NV and Arseus BV.

Arseus Profile

Arseus is a multinational group of companies that supplies products, services and concepts to professionals and institutions in the healthcare sector in 30 countries worldwide. Arseus is subdivided into four divisions and operates in the markets for pharmaceutical compounding for pharmacies, dental products, medical and surgical products, and medical ICT-solutions. The Belgian company Arseus NV is located in Waregem, and is listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam. The operational activities of the Arseus group are driven by the Dutch company Arseus BV. The head office of Arseus BV is located in Rotterdam.